Effect of Rosiglitazone, a PPAR-γ Ligand on Haloperidol-Induced CatalepsyGUPTA, Gaurav; SINGH, Ramandeep; SHEBA RANI DAVID et al.CNS neuroscience & therapeutics (Print). 2013, Vol 19, Num 9, pp 724-725, issn 1755-5930, 2 p.Article

HALOPERIDOLJANICKI CA; CHAN YAN KO.1980; ANAL. PROFILES DRUG SUBST.; ISSN 0099-5428; USA; DA. 1980; VOL. 9; PP. 341-369; BIBL. 39 REF.Article

HALOPERIDOL FOR RADIATION SICKNESS. CONTROL OF ASSOCIATED NAUSEA, VOMITING, AND ANOREXIA = L'HALOPERIDOL DANS LE MAL DES RAYONS. CONTROLE DES NAUSEES, DES VOMISSEMENTS ET DE L'ANOREXIE ASSOCIESCOLE DR; DUFFY DF.1974; NEW YORK STATE J. MED.; U.S.A.; DA. 1974; VOL. 74; NO 9; PP. 1558-1562; BIBL. 10REF.Article

The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variationLINGJUN ZUO; XINGGUANG LUO; KRYSTAL, John H et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 6, pp 437-446, issn 1744-6872, 10 p.Article

Stability Studies of Clonazepam, Diazepam, Haloperidol, and Doxepin with Diverse Polarities in an Acidic EnvironmentMASLANKA, Anna; KRZEK, Jan; STOLARCZYK, Mariusz et al.Journal of AOAC International. 2011, Vol 94, Num 6, pp 1791-1799, issn 1060-3271, 9 p.Article

INTRAMUSCULAR HALOPERIDOL DECANOATE FOR NEUROLEPTIC MAINTENANCE THERAPY. EFFICACY, DOSAGE SCHEDULE AND PLASMA LEVELS. AN OPEN MULTICENTER STUDYDEBERDT R; ELENS P; BERGHMANS W et al.1980; ACTA PSYCHIATR. SCAND.; ISSN 0001-690X; DNK; DA. 1980; VOL. 62; NO 4; PP. 356-363; BIBL. 9 REF.Article

HALOPERIDOL BINDING TO AN OPIATE RECEPTOR SITECLAY GA; BROUGHAM LR.1975; BIOCHEM. PHARMACOL.; G.B.; DA. 1975; VOL. 24; NO 13-14; PP. 1363-1367; BIBL. 13REF.Article

EFFECT OF HALOPERIDOL ADMINISTRATION ON SERUM MHPG-SO4 LEVELS IN CHRONIC SCHIZOPHRENICSHOKAI Y; NISHIKAWA T; IDA Y et al.1981; KURUME MED. J.; ISSN 0023-5679; JPN; DA. 1981; VOL. 28; NO 3; PP. 197-200; BIBL. 10 REF.Article

HALOPERIDOL: FIFTEEN YEARS OF CLINICAL EXPERIENCE = HALOPERIDOL: 15 ANNEES D'EXPERIENCE CLINIQUEAYD FJ JR.1972; DIS. NERV. SYST.; U.S.A.; DA. 1972; VOL. 33; NO 7; PP. 459-469; BIBL. 2P.Serial Issue

HALOPERIDOL: TWENTY YEARS' CLINICAL EXPERIENCEAYD FJ JR.1978; J. CLIN. PSYCHIATRY; USA; DA. 1978; VOL. 39; NO 11; PP. 807-814; BIBL. 76 REF.Article

AN OPERANT COUNTING SCALE FOR CHILDREN: A PRELIMINARY METHODOLOGICAL PSYCHOACTIVE-DRUG CASE STUDYSHEINBEIN ML; WIGGINS KM.1975; CHILD PSYCHIATRY HUM. DEVELOP.; U.S.A.; DA. 1975; VOL. 5; NO 3; PP. 142-149; BIBL. 1P.1/2Article

POLAROGRAPHISCHE BESTIMMUNG VON BUTYROPHENONDERIVATEN IN BLUT = DOSAGE POLAROGRAPHIQUE DES DERIVES DE LA BUTYROPHENONE DANS LE SANGMIKOLAJEK A; KRZYZANOWSKA A; FIDELUS J et al.1974; Z. (FRESENIUS') ANAL. CHEM.; DTSCH.; DA. 1974; VOL. 272; NO 1; PP. 39-42; ABS. ANGL.; BIBL. 4REF.Article

Despite irreversible binding, PET tracer [¹¹C]-SA5845 is suitable for imaging of drug competition at sigma receptors : The cases of ketamine and haloperidolKORTEKAAS, Rudie; MAGUIRE, R. Paul; VAN WAARDE, Aren et al.Neurochemistry international. 2008, Vol 53, Num 1-2, pp 45-50, issn 0197-0186, 6 p.Article

Interindividual variation of serum haloperidol concentrations in Japanese patients: clinical considerations on steady-state serum level-dose ratiosYUKAWA, E; ICHIMARU, R; MAKI, T et al.Journal of clinical pharmacy and therapeutics (Print). 2003, Vol 28, Num 2, pp 97-101, issn 0269-4727, 5 p.Article

The timing of haloperidol administration does not affect its prophylactic antiemetic efficacyYANG, Yao L; LAI, Hsien Y; WANG, Jhi J et al.Canadian journal of anaesthesia. 2008, Vol 55, Num 5, pp 270-275, issn 0832-610X, 6 p.Article

Delayed reactivation of haloperidol induced photosensitive dermatitis by methotrexateTHAMI, G. P; KAUR, S; KANWAR, A. J et al.Postgraduate medical journal. 2002, Vol 78, Num 916, pp 116-117, issn 0032-5473Article

Neuroleptic malignant syndrome : An atypical presentationNG, D.Current therapeutics. 1997, Vol 38, Num 11, pp 63-64, issn 0311-905XArticle

Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidolGIEGLING, Ina; DRAGO, Antonio; RUJESCU, Dan et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 4, pp 206-216, issn 1744-6872, 11 p.Article

La découverte de l'halopéridol = The discovery of haloperidolGRANGER, B.L' Encéphale (Paris). 1999, Vol 25, Num 1, pp 59-66, issn 0013-7006Conference Paper

Haloperidol plasma levels and dose optimizationCORYELL, W; MILLER, D. D; PERRY, P. J et al.The American journal of psychiatry. 1998, Vol 155, Num 1, pp 48-53, issn 0002-953XArticle

Effects of a quaternary pyridinium metabolite of haloperidol (HP⁺) on the viability and catecholamine levels of cultured PC12 cellsFANG, J; YU, P. H.Canadian journal of physiology and pharmacology. 1997, Vol 75, Num 8, pp 996-1000, issn 0008-4212Article

BEYOND THE BASAL GANGLIA: cFOS EXPRESSION IN THE CEREBELLUM IN RESPONSE TO ACUTE AND CHRONIC DOPAMINERGIC ALTERATIONSHERRERA-MEZA, G; AGUIRRE-MANZO, L; CORIA-AVILA, G. A et al.Neuroscience. 2014, Vol 267, pp 219-231, issn 0306-4522, 13 p.Article

A SIMPLE METHOD FOR DETECTION OF FOOD FORAGING BEHAVIOR IN THE RAT: INVOLVEMENT OF NMDA AND DOPAMINE RECEPTORS IN THE BEHAVIORLI, F; CAO, W. Y; LI, M. B et al.Neuroscience. 2012, Vol 205, pp 73-80, issn 0306-4522, 8 p.Article

Haloperidol modulates noradrenergic responses to aversive stimulation depending on treatment durationAMATO, Davide; NATESAN, Sridhar; KAPUR, Shitij et al.Behavioural brain research. 2011, Vol 221, Num 1, pp 311-313, issn 0166-4328, 3 p.Article

Interaction of haloperidol plasma level and antipsychotic effect in early phases of acute psychosis treatmentGIEGLING, Ina; DRAGO, Antonio; SCHÄFER, Martin et al.Journal of psychiatric research. 2010, Vol 44, Num 8, pp 487-492, issn 0022-3956, 6 p.Article